POLICY
Industry Could Lose Battle over Language for Comparative Effectiveness Research
A House-Senate conference committee last night settled on a provision of the stimulus package that could be critical to the biotech and pharmaceutical industry in the coming years, nailing down the details of a $1.1 billion fund for comparative effectiveness research.
Cash Boost Coming for Stagnant U.S. Medical Research
After years of stagnant funding, medical research in the United States is set for a big cash infusion that experts expect will boost work on a range of ailments as well studies involving human embryonic stem cells.
F.D.A. Consolidates at Former Navy Site
The Food and Drug Administration has moved into the Naval Surface Warfare Center in White Oak, consolidating its previously scattered labs and offices.
Maryland Stem Cell Research Commission's Focus to Change
Maryland Stem Cell Research Commission members hashed out plans for the group's future Tuesday, as they discussed a new bill that would reorganize the commission to include biotechnology and change the purpose of the fund.
|